Table 3.
Study identifier
|
Cell type
|
Aim of the study
|
NCT03119636[62] | hESC-NPCs | Safety and efficacy evaluation of intracerebral transplantation |
NCT05635409[63] | hESC-DA neurons | Safety and tolerability evaluation of intraputamenal transplantation |
NCT02452723[64] | ISC-hpNSC® | Safety evaluation of intracerebral transplantation |
NCT03815071[65] | iPS-NSCs | Safety and efficacy evaluation |
UMIN000033564[66] | iPSC-derived dopaminergic progenitors | Safety and efficacy of transplantation into the corpus striatum |
NCT03128450[67] | hNSCs | Safety and efficacy evaluation of nasal delivery |
NCT03309514[68] | NSC-derived neurons | Safety and efficacy evaluation of intracerebral injection |
NCT01898390[69] | hVMT | Safety and efficacy evaluation |
NCT02795052[70] | BMSC | Efficacy evaluation of intravenous and intranasal delivery |
NCT00976430[71] | BMSC | Safety and efficacy evaluation |
NCT03724136[72] | BMSC | Efficacy evaluation of intravenous and intranasal delivery on cognitive impairment |
NCT03684122[73] | Umbilical cord derived MSCs differentiated into NSCs | Safety evaluation of intrathecal and intravenous injections |
BMSC: Bone-marrow-derived stem cell; iPS-NSC cells: Pluripotent stem-cell-derived neural stem cells; ISC-hpNSC®: Human parthenogenetic stem-cell-derived neural stem cells developed by international stem cell corporation; hNSCs: Human neural stem cells; hVMT: Human ventral mesencephalon tissue; hESC-NPCs: Human embryonic stem cells-derived neural precursor cells.